e-learning
resources
Vienna 2009
Monday, 14.09.2009
Clinical immunology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Screening for tuberculosis in candidates for immunosuppressive therapy
I. Gonçalves, D. Alves, F. Guedes, A. Carvalho, R. Duarte (Vila Nova de Gaia, Portugal)
Source:
Annual Congress 2009 - Clinical immunology of tuberculosis
Session:
Clinical immunology of tuberculosis
Session type:
Thematic Poster Session
Number:
2561
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Gonçalves, D. Alves, F. Guedes, A. Carvalho, R. Duarte (Vila Nova de Gaia, Portugal). Screening for tuberculosis in candidates for immunosuppressive therapy. Eur Respir J 2009; 34: Suppl. 53, 2561
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
Persistent fever and cytopenia in a patient with pulmonary tuberculosis
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Experience of isofon use for therapy and chemoprophylaxis of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004
Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART
Source: Breathe 2008; 5: 274
Year: 2009
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Unmasking tuberculosis in the era of antiretroviral treatment
Source: Eur Respir J 2012; 39: 1064-1075
Year: 2012
Resistance to second-line antituberculous drugs of
Mtb
strains in TB institute clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 442s
Year: 2007
Diaskintest at patients after successful treatment of lung tuberculosis
Source: International Congress 2017 – Migrants and screening
Year: 2017
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J 2014; 43: 884-897
Year: 2014
Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Development of new drug products for inhalation therapy of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004
Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 197s
Year: 2007
Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007
Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006
The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001
Reasons for hepatotoxic reactions to chemotherapeutic agents and possibilities of their prevention in adolescents with tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept